Sign In
Buy INO
$1.14
-0.0700 (-5.79%)
At Close: Jun 03, 2026
Why Dynavax Technologies, Heat Biologics, and Inovio Pharmaceuticals Are Cratering Today
11:27am, Tuesday, 11'th Aug 2020
Russia's surprise vaccine announcement isn't sitting well with shareholders of Dynavax, Heat Biologics, or Inovio Pharmaceuticals.
Inovio To Start Phase 2/3 Study Of Covid-19 Candidate In Sept.; Shares Drop 8%
08:49am, Tuesday, 11'th Aug 2020
Inovio Pharmaceuticals Inc. plans to initiate Phase 2/3 study trials of INO-4800, its experimental vaccine candidate against the novel coronavirus, in September and produce at least 1 million doses th
Stifel cuts COVID-19 vaccine developer Inovio's price target as earnings and call leave more questions than answers
07:35am, Tuesday, 11'th Aug 2020
Stifel analysts cut their stock price target for Inovio Pharmaceuticals Inc. INO, -6.08% to $16 from $24 on Tuesday, after the company posted a wider-than-expected second-quarter loss and revenue that
Inovio Pharmaceuticals (INO) Q2 2020 Earnings Call Transcript
06:30am, Tuesday, 11'th Aug 2020
INO earnings call for the period ending June 30, 2020.
Inovio Coronavirus Vaccine To Enter Mid-To-Late Stage Testing In September
04:00am, Tuesday, 11'th Aug 2020
Inovio Pharmaceuticals Inc (NASDAQ: INO) said during the earnings call Monday it expected its COVID-19 vaccine to enter mid-to-late stage human trials in September, Reuters reported.Coronavirus Vaccin
Inovio to begin mid-to-late stage study of COVID-19 vaccine candidate in September
02:52am, Tuesday, 11'th Aug 2020
The Plymouth Meeting, Pennsylvania-based company had previously said it would begin mid-stage human studies for the vaccine candidate, INO-4800, this summer. Inovio is in active talks with the U.S. F
Inovio Coronavirus Vaccine To Enter Mid-To-Late Stage Testing In September
12:00am, Tuesday, 11'th Aug 2020
Inovio Pharmaceuticals Inc (NASDAQ: INO) said during the earnings call Monday it expected its COVID-19 vaccine to enter mid-to-late stage human trials in September, Reuters reported.
Inovio Pharmaceuticals, Inc. (INO) CEO J.
09:35pm, Monday, 10'th Aug 2020
Inovio Pharmaceuticals, Inc. (INO) CEO J.
Inovio Pharma stock fluctuates after results, vaccine update
09:17pm, Monday, 10'th Aug 2020
Inovio Pharmaceuticals Inc. shares fluctuated between slight gains and losses in the extended session Monday after the biotech company reported results that fell short of Wall Street estimates while
INOVIO Reports Second Quarter 2020 Financial Results; Provides DNA Medicines Clinical Program Mid-Year Update
08:05pm, Monday, 10'th Aug 2020
INOVIO (NASDAQ:INO), a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, today reported fina
Inovio Pharma stock fluctuates after results, vaccine update
05:17pm, Monday, 10'th Aug 2020
Inovio Pharmaceuticals Inc. INO, -6.08% shares fluctuated between slight gains and losses in the extended session Monday after the biotech company reported results that fell short of Wall Street estim
T Cell Responses To Coronavirus Vaccines Are In The Interest Of National Security
04:39pm, Monday, 10'th Aug 2020
COVID-19 has weakened the US economy more than China's.
INOVIO Reports Second Quarter 2020 Financial Results; Provides DNA Medicines Clinical Program Mid-Year Update
04:05pm, Monday, 10'th Aug 2020
PLYMOUTH MEETING, Pa., Aug. 10, 2020 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people fro
Zacks: Analysts Anticipate Inovio Pharmaceuticals Inc (NASDAQ:INO) Will Post Quarterly Sales of $2.08 Million
07:36pm, Sunday, 09'th Aug 2020
Equities analysts expect that Inovio Pharmaceuticals Inc (NASDAQ:INO) will post sales of $2.08 million for the current quarter, Zacks reports. Four analysts have provided estimates for Inovio Pharmace
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
12:00am, Sunday, 09'th Aug 2020
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus...
